Vimta Labs Q4 FY26 Net Profit Up 15.2% YoY

Vimta Labs reported Q4 FY26 results with revenue of INR1,120 million, up 16.6% YoY, and PAT of INR211 million, up 15.2% YoY.
The company announced its entry into biologics contract research and development services, with infrastructure and team ready for FY27 execution.
Management highlighted strong EBITDA margins of 35.8% for FY26 and maintained a net debt-free balance sheet with INR650 million cash.
The transcript of the earnings call held on May 6, 2026, was disclosed per SEBI LODR regulations and made available on the company website.